Updated:
Decheng Capital
Decheng Capital is a global life sciences investment firm based in Menlo Park, California. Founded in 2012, it invests in early-stage life science companies...
Overview
Decheng Capital is a global life sciences investment firm based in Menlo Park, California. Founded in 2012, it invests in early-stage life science companies and growth-stage healthcare companies. Decheng Capital has made 125 investments, including a Series B investment in Syneron Bio on March 31, 2026.
General information
Firm type
Generalist
Year founded
2012
AUM
$2.5B
Location
Region
Asia
Country
China
City
Shanghai
Corporate office
Shanghai, China
Sector focus
Frequently asked questions
What stages does Decheng Capital target?
Records show coverage of early-stage seed, start-up, expansion, growth, and pre-IPO opportunities.
Where is Decheng Capital based?
Headquarters are in Shanghai, China.
Profile maintained by Altss. Updated: . To correct this record or make a privacy request, send the page URL and your evidence to privacy@altss.com; corrections are free.
Need institutional-grade insight on asset managers?
Altss delivers:
Prefer a guided tour?
We’ll walk you through: